Oral Obesity Therapies market to reach $6.32 billion by 2030 at 9.9% CAGR, driven by increasing obesity prevalence, oral GLP-1 adoption, and personalized metabolic treatments.
Oral Microbiome Products market to reach $2.08 billion by 2030 at 14.5% CAGR, driven by rising dental diseases, aging populations, and demand for personalized oral care.
Ophthalmology Devices market to reach $99.22 billion by 2030 at 11.9% CAGR, driven by increasing eye disorders, vision care spending, and advanced surgical technologies.
Non-Animal Stabilized Hyaluronic Acid Fillers market to reach $1.85 billion by 2030 at 13.6% CAGR, driven by minimally invasive aesthetic procedures and personalized beauty trends.